[1]
Zwitter, M. et al. 2017. SELECTION OF NON-SMALL CELL LUNG CANCER PATIENTS FOR INTERCALATED CHEMOTHERAPY AND TYROSINE KINASE INHIBITORS. Radiology and Oncology. 51, 3 (Sep. 2017).